Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
Nicoletta Caronni, Giulia Maria Piperno, Francesca Simoncello, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 2708-3145
Open Access | Times Cited: 314
Dendritic cell subsets in cancer immunity and tumor antigen sensing
Annalisa Del Prete, Valentina Salvi, Alessandra Soriani, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 5, pp. 432-447
Open Access | Times Cited: 251
Human dendritic cells in cancer
Egle Kvedaraite, Florent Ginhoux
Science Immunology (2022) Vol. 7, Iss. 70
Closed Access | Times Cited: 163
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 98
Cross-priming in cancer immunology and immunotherapy
Carlos Luri‐Rey, Álvaro Teijeira, Stefanie K. Wculek, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer
Brett H. Herzog, John Baer, Nicholas Borcherding, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 699
Closed Access | Times Cited: 38
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors
Lucía López, Luciano Gastón Morosi, Federica La Terza, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Dendritic Cells in Shaping Anti-Tumor T Cell Response
Luciano Mazzoccoli, Bei Liu
Cancers (2024) Vol. 16, Iss. 12, pp. 2211-2211
Open Access | Times Cited: 14
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Tim4 enables large peritoneal macrophages to cross-present tumor antigens at early stages of tumorigenesis
Sonal Joshi, Lucía López, Luciano Gastón Morosi, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114096-114096
Open Access | Times Cited: 8
Tumor‐associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevance
Ioana Plesca, Luise Müller, Jan P. Böttcher, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 11, pp. 1750-1758
Open Access | Times Cited: 35
CXCL5-mediated accumulation of mature neutrophils in lung cancer tissues impairs the differentiation program of anticancer CD8 T cells and limits the efficacy of checkpoint inhibitors
Francesca Simoncello, Giulia Maria Piperno, Nicoletta Caronni, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Immune cellular components and signaling pathways in the tumor microenvironment
Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 187-201
Open Access | Times Cited: 33
A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types
Mattia Bugatti, Marco Bergamini, Francesco Missale, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 11, pp. 1340-1353
Open Access | Times Cited: 31
Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance
Theodora Katopodi, Savvas Petanidis, Charalampos Charalampidis, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3183-3183
Open Access | Times Cited: 28
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy
Christine Moussion, Lélia Delamarre
Seminars in Immunology (2023) Vol. 71, pp. 101848-101848
Closed Access | Times Cited: 15
On the Biology and Therapeutic Modulation of Macrophages and Dendritic Cells in Cancer
Matthew D. Park, Meriem Belabed, Steven T. Chen, et al.
Annual Review of Cancer Biology (2023) Vol. 7, Iss. 1, pp. 291-311
Open Access | Times Cited: 14
DNGR-1-mediated cross-presentation of dead cell-associated antigens
Conor M. Henry, Carlos A. Castellanos, Caetano Reis e Sousa
Seminars in Immunology (2023) Vol. 66, pp. 101726-101726
Open Access | Times Cited: 13
A Novel Polymersome Nanocarrier Promotes Anti‐Tumour Immunity by Improved Priming of CD8+ T Cells
Regine J. Dress, William W. Ho, Victor Ho, et al.
Immunology (2025)
Open Access
Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access
ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors
Luciano Gastón Morosi, Giulia Maria Piperno, Lucía López, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy
Laura Rodríguez, Roberto M. Amadio, Giulia Maria Piperno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010547-e010547
Open Access
XCR1+ and IRF4+ migratory dendritic cells cooperate for the cross-priming of intratumoral CD8+ T cells with a tissue-resident memory phenotype.
Nathan Vaudiau, Pierre Bourdely, Agathe Ok, et al.
(2025)
Closed Access
Cancer cell membrane proteins-encapsulated nanovaccine enhances cancer immunotherapy and prevention by provoking antigen-specific cellular immunity via the dendritic cell-targeted delivery
Xingyu Luo, Xiaolu Chen, Rongying Ma, et al.
Chemical Engineering Journal (2024) Vol. 481, pp. 148611-148611
Closed Access | Times Cited: 3
Focused ultrasound ablation of melanoma with boiling histotripsy yields abscopal tumor control and antigen-dependent dendritic cell activation
E. Andrew Thim, Lydia E. Kitelinger, Fátima Rivera‐Escalera, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1647-1661
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top